Haemophilia B
·MeSH: Hemophilia B
Prevalence
5.0 / 100K
3 drugs in development·1 company·7 clinical trials
Drug Pipeline by Phase
Phase 3(2)
Unknown(1)
| Drug | Company |
|---|---|
| refixia | Novo Nordisk A/S (NVO) |
Compare drugs
Frequently asked questions
How many drugs are in development for Haemophilia B?
BioSniper tracks 3 drugs in development for Haemophilia B across 1 company.
How many clinical trials target Haemophilia B?
There are 7 clinical trials targeting Haemophilia B tracked by BioSniper.
What is the prevalence of Haemophilia B?
The estimated prevalence of Haemophilia B is approximately 5.0 per 100,000 population.
Deep-dive into Haemophilia B
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis